D-0284-2022 Class II Terminated
FDA drug recall D-0284-2022 was initiated by Valgene Incorporated dba Cape Drugs on December 3, 2021 and is designated Class II. Reason for recall: Lack of Processing Controls The recall status is terminated (terminated January 4, 2022). Affected quantity: 12 vials.
Recall Details
- Product Type
- Drugs
- Report Date
- December 22, 2021
- Initiation Date
- December 3, 2021
- Termination Date
- January 4, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 12 vials
Product Description
B-Complex, injection, 1 mL vials, Rx only, Cape Drugs 1384 Cape St. Claire Road Annapolis, MD 21409
Reason for Recall
Lack of Processing Controls
Distribution Pattern
Maryland Only
Code Information
Lot# 190036, BUD 12/27/2021